Home › NCT06598319
Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis
Recruiting
Who can join
Ages 18 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. The subject is 18 to 85 years of age. 2. The subject has had symptoms of chronic rhinitis for greater than 6 months with insufficient response to nasal steroids. 3. The subject has an rTNSS total score of ≥ 6. 4. The subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion (rTNSS rating of 2 or 3 for rhinorrhea and 1, 2, or 3 for congestion) 5. The subject is able and willing to provide written informed consent and comply with the protocol requirements. Exclusion Criteria: 1. The subject has clinically significant anatomic obstructions on either side that limit access to the posterior nose, including severe septal deviation, nasal polyps, and sinonasal tumor 2. The subject has a septal perforation 3. The subject has had prior sinus or nasal surgery on either side that significantly alters the anatomy of the posterior nose. 4. The subject had had previous surgery of the PNN for chronic rhinitis. 5. The subject has had prior head or neck irradiation 6. The subject has an active or chronic nasal or sinus infection 7. The subject has active coagulation disorder, or the patient is receiving anticoagulants 8. The subject has a history of dry eye or dry nose symptoms 9. Patient has rhinitis medicamentosa 10. The subject has ocular allergic symptoms 11. The subject has a history of nose bleeds 12. The subject has electrically sensitive implants (e.g. cochlear implants, pacemakers, defibrillators) 13. The subject is pregnant or lactating 14. The subject is participating in another clinical research study 15. The subject has an allergy or intolerance to anesthetic agent 16. Any physical condition that, in the Investigator's opinion, would prevent adequate study participation or pose an increased risk
About the study
Evaluation of safety, effectiveness and tolerability of the Aventix Medical Device used for the treatment of chronic rhinitis
What is being tested
- NOVOCLEAR™ Device (device)
Sponsor: Aventix Medical Inc. · Participants: 30 · Started: Nov 15, 2024
Contact the study team
- ClinicalAdmin · Phone: (510) 912-2589
Official record on ClinicalTrials.gov — NCT06598319
Locations in the U.S.
| Colorado | Colorado ENT and Allergy, Colorado Springs |
| Mississippi | Bay Area ENT, Ocean Springs |
| Texas | Atkins Expert Sinus Care, San Antonio |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.